Yavuz Havlucu
Overview
Explore the profile of Yavuz Havlucu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kizilirmak D, Yilmaz Kaya Z, Gokcimen G, Havlucu Y, Ozyurt B, Gundogus B, et al.
Cancer Epidemiol
. 2023 Oct;
87:102480.
PMID: 37897971
Background: Lung cancer is the leading cause of cancer-related deaths worldwide. Before beginning lung cancer treatment, it is necessary to complete procedures such as suspecting lung cancer, obtaining a pathologic...
12.
Kizilirmak D, Sari S, Can F, Havlucu Y
BMC Pulm Med
. 2023 Jun;
23(1):234.
PMID: 37391786
Background: Following COVID-19 infection, some patients acquired lung injury and fibrosis. Idiopathic pulmonary fibrosis is characterized by lung fibrosis. Both post-COVID lung injury and idiopathic pulmonary fibrosis cause loss of...
13.
Kizilirmak D, Fidan U, Sari S, Havlucu Y
Tuberk Toraks
. 2023 Jun;
71(2):123-130.
PMID: 37345394
Introduction: Post-COVID period is considered to be 12 weeks after the COVID-19 infection. Patients in the post-COVID period may have prolonged or newly developed symptoms. Depending on the prolonged effects...
14.
Celik G, Aydin O, Gokmen D, Koycu Buhari G, Celebi Sozener Z, Gemicioglu B, et al.
J Asthma
. 2023 Apr;
60(11):1973-1986.
PMID: 37096963
Introduction: National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry...
15.
Kizilirmak D, Yilmaz Z, Havlucu Y, Celik P
SN Compr Clin Med
. 2022 Dec;
5(1):23.
PMID: 36540424
Non-COVID hospital admissions decreased during the COVID-19 pandemic and follow-up of people in the lung cancer risk group was delayed. There are not enough studies on the effects of the...
16.
Babayigit C, Kokturk N, Kul S, Duru Cetinkaya P, Nayci S, Argun Baris S, et al.
Front Med (Lausanne)
. 2022 Sep;
9:894126.
PMID: 36117966
Background And Objectives: Although several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives...
17.
Sak I, Kizilirmak D, Havlucu Y, Yilmaz Z, Celik P
Tuberk Toraks
. 2022 Apr;
70(1):102-106.
PMID: 35362310
Ataxia-telangiectasia is an autosomal recessive, rare, neurodegenerative multisystem disorder characterized by ataxia-telangiectasia, cerebellar ataxia, oculocutaneous telangiectasia, immunodeficiency, progressive respiratory failure associated with increased malignancy risk. Clinical diagnosis is made with...
18.
Uzun O, Akpolat T, Varol A, Turan S, Gokbulut Bektas S, Duru Cetinkaya P, et al.
Infection
. 2022 Jan;
50(3):747-752.
PMID: 34984646
Objective: Vaccination is the most efficient way to control the coronavirus disease 2019 (COVID-19) pandemic, but vaccination rates remain below the target level in most countries. This multicenter study aimed...
19.
Gemicioglu B, Yalcin A, Havlucu Y, Karakaya G, Ozdemir L, Keren M, et al.
Turk J Med Sci
. 2021 Jun;
51(5):2516-2523.
PMID: 34174791
Background/aim: We aimed to report outcomes of pregnant patients with asthma under omalizumab treatment and their infants in our country. Materials And Methods: Patients with asthma who received omalizumab for...
20.
Kokturk N, Babayigit C, Kul S, Duru Cetinkaya P, Nayci S, Argun Baris S, et al.
Respir Med
. 2021 May;
183:106433.
PMID: 33957434
The COVID-19-related death rate varies between countries and is affected by various risk factors. This multicenter registry study was designed to evaluate the mortality rate and the related risk factors...